A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
NCT01592552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2023-11-22
Summary
The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
Conditions
- Alzheimer's Disease
- Multiple Sclerosis
- Parkinson's Disease
- Huntington's Disease
- Amyotrophic Lateral Sclerosis (ALS)
Sponsors & Collaborators
-
Sanguine Biosciences
lead INDUSTRY
Principal Investigators
-
Phil Silkoff, MD · Sanguine Biosciences
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- United States
Study Locations
More Related Trials
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT03225144 ·Status: RECRUITING
-
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450 ·Status: ENROLLING_BY_INVITATION
-
Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease
NCT02605161 ·Status: COMPLETED
-
Study to Understand Novel Biomarkers in Researching Dementia
NCT06547099 ·Status: RECRUITING
-
Circulating Ghrelin as a Biomarker for Dementia
NCT05381090 ·Status: RECRUITING ·Phase: NA
-
Biomarkers and Early Alzheimer's Disease
NCT00094952 ·Status: UNKNOWN
-
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment
NCT01425957 ·Status: COMPLETED ·Phase: NA
-
Biomarker Study to Diagnose Alzheimer's Disease
NCT01874418 ·Status: UNKNOWN ·Phase: NA
-
Ruijin Neurobank of Alzheimer's Disease and Dementia
NCT05623124 ·Status: RECRUITING
-
The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)
NCT03702816 ·Status: TERMINATED ·Phase: PHASE2
-
Big Data and Genomic Imaging for the Development of Biomarkers and Nanovector Drugs Innovative for Diagnosis and Therapy of Inflammatory Processes in Dementia
NCT05761535 ·Status: COMPLETED
-
Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation
NCT06551649 ·Status: RECRUITING ·Phase: NA
-
Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
NCT02612376 ·Status: TERMINATED
-
The Swedish BioFINDER Study
NCT01208675 ·Status: COMPLETED
-
Biomarker Study for Alzheimer's Disease
NCT02472899 ·Status: COMPLETED
-
A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)
NCT01325662 ·Status: COMPLETED
-
Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
NCT06516016 ·Status: NOT_YET_RECRUITING
-
Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
NCT07314190 ·Status: ENROLLING_BY_INVITATION
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
Venous Obstruction in Neurodegenerative Disorders Research Registry
NCT01593358 ·Status: UNKNOWN
-
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT05582200 ·Status: RECRUITING
-
Quantitative Imaging of Brain Glymphatic Function in Humans
NCT04768101 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
The GBA Multimodal Study in Parkinson's Disease
NCT04101968 ·Status: RECRUITING
-
Brain Tissue Specimen Collection
NCT00593203 ·Status: ENROLLING_BY_INVITATION